Xenetic Biosciences logo

Xenetic Biosciences Share Price Today

(NASDAQ: XBIO)

Xenetic Biosciences share price is $3.83 & ₹333.09 as on 6 Mar 2025, 2.30 'hrs' IST

$3.83

-0.06

(-1.54%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Xenetic Biosciences share price in Dollar and Rupees. Guide to invest in Xenetic Biosciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Xenetic Biosciences, along with analyst recommendations, forecasts, and comprehensive financials.

Xenetic Biosciences share price movements

  • Today's Low: $3.83
    Today's High: $4.12

    Day's Volatility :7.05%

  • 52 Weeks Low: $2.78
    52 Weeks High: $5.20

    52 Weeks Volatility :46.54%

Xenetic Biosciences (XBIO) Returns

PeriodXenetic Biosciences IncIndex (Russel 2000)
3 Months
-13.75%
0.0%
6 Months
2.37%
0.0%
1 Year
-8.07%
0.0%
3 Years
-55.64%
-11.6%

Xenetic Biosciences (XBIO) Key Statistics

in dollars & INR

Previous Close
$3.8899
Open
$3.83
Today's High
$4.1204
Today's Low
$3.83
Market Capitalization
$6.0M
Today's Volume
$4.3K
52 Week High
$5.2
52 Week Low
$2.78
Revenue TTM
$2.5M
EBITDA
$-5.7M
Earnings Per Share (EPS)
$-2.66
Profit Margin
-161.58%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-45.48%

How to invest in Xenetic Biosciences Stock (XBIO) from India?

It is very easy for Indian residents to invest directly in Xenetic Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Xenetic Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Xenetic Biosciences or XBIO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Xenetic Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Xenetic Biosciences shares which would translate to 0.227 fractional shares of Xenetic Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Xenetic Biosciences, in just a few clicks!

Returns in Xenetic Biosciences (XBIO) for Indian investors in Rupees

The Xenetic Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Xenetic Biosciences investment value today

Current value as on today

₹95,507

Returns

₹4,493

(-4.49%)

Returns from Xenetic Biosciences Stock

₹9,456 (-9.46%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Xenetic Biosciences (XBIO)

-25%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Xenetic Biosciences Stock from India on INDmoney has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Xenetic Biosciences

  • Renaissance Technologies Corp

    1.66%

  • Susquehanna International Group, LLP

    1.03%

  • Citadel Advisors Llc

    0.87%

  • Geode Capital Management, LLC

    0.77%

  • Sachetta LLC

    0.48%

  • JTC Employer Solutions Trustee Ltd

    0.18%

Analyst Recommendation on Xenetic Biosciences

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Xenetic Biosciences(by analysts ranked 0 to 5 stars)

Based on 6 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
0
0
0
Hold
3
3
3
Sell
3
3
3

Analyst Forecast on Xenetic Biosciences Stock (XBIO)

What analysts predicted

Upside of 944.39%

Target:

$40.00

Current:

$3.83

Insights on Xenetic Biosciences Stock (Ticker Symbol: XBIO)

  • Price Movement

    In the last 7 days, XBIO stock has moved down by -1.0%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 726.40K → 614.24K (in $), with an average decrease of 15.4% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -1.27M → -436.67K (in $), with an average increase of 191.8% per quarter
  • XBIO vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 67.2%
  • XBIO vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 105.0%
  • Price to Sales

    ForXBIO every $1 of sales, investors are willing to pay $2.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Xenetic Biosciences Technicals Summary

Sell

Neutral

Buy

Xenetic Biosciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Xenetic Biosciences (XBIO) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Xenetic Biosciences Inc logo
-4.19%
2.37%
-8.07%
-55.64%
-49.99%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Xenetic Biosciences Inc logo
NA
NA
0.0
0.0
-0.45
-0.27
NA
4.56
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Xenetic Biosciences Inc logo
Sell
$6.0M
-49.99%
NA
-161.58%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Xenetic Biosciences

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing immune-oncology technologies for hard to treat cancers. The company's proprietary DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments that targets pancreatic cancer comprising pancreatic ductal adenocarcinoma, colorectal carcinoma, and other gastrointestinal cancer. Its product pipeline includes XBIO-015 for treating pancreatic carcinoma and solid tumors; and XBIO-020 for treating solid tumors. The company also has partnered with biotechnology and pharmaceutical companies to develop its proprietary drug delivery platform, PolyXen, which as an enabling platform technology for protein and peptide drug delivery. It has collaboration agreements with Belgian Volition SARL Limited to develop NETs-targeted adoptive cell therapies for the treatment of cancer, as well as PJSC Pharmsynthez and Serum Institute of India to develop and launch ErepoXen for the treatment of anemia in chronic kidney disease patients; sublicensing agreement with Takeda Pharmaceutical Co. Ltd; exclusive sublicense agreement with CLS Therapeutics Ltd to develop and commercialize pharmaceutical products and methods incorporating DNase enzyme for use in treatment of cancer; and exclusive license agreement with CLS Therapeutics Ltd to develop and commercialize pharmaceutical products and methods incorporating DNase in conjunction with CAR T therapies. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.
Organization
Xenetic Biosciences
Employees
4
CEO
Mr. James F. Parslow
Industry
Health Technology

Management People of Xenetic Biosciences

NameTitle
Mr. James F. Parslow
CFO, COO, Interim CEO & Corporate Secretary

Important FAQs about investing in XBIO Stock from India :

What is Xenetic Biosciences share price today?

Xenetic Biosciences share price today stands at $3.83, Open: $3.83 ; Previous Close: $3.89 ; High: $4.12 ; Low: $3.83 ; 52 Week High: $5.20 ; 52 Week Low: $2.78.

The stock opens at $3.83, after a previous close of $3.89. The stock reached a daily high of $4.12 and a low of $3.83, with a 52-week high of $5.20 and a 52-week low of $2.78.

Can Indians buy Xenetic Biosciences shares?

Yes, Indians can invest in the Xenetic Biosciences (XBIO) from India.

With INDmoney, you can buy Xenetic Biosciences at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Xenetic Biosciences at zero transaction cost.

How can I buy Xenetic Biosciences shares from India?

It is very easy to buy Xenetic Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Xenetic Biosciences (XBIO) be purchased?

Yes, you can buy fractional shares of Xenetic Biosciences with INDmoney app.

What are the documents required to start investing in Xenetic Biosciences stocks?

To start investing in Xenetic Biosciences, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Xenetic Biosciences Stock (XBIO)?

Today’s highest price of Xenetic Biosciences (XBIO) is $4.12.

Today’s lowest price of Xenetic Biosciences (XBIO) is $3.83.

What is today's market capitalisation of Xenetic Biosciences?

Today's market capitalisation of Xenetic Biosciences XBIO is 6.0M

What is the 52 Week High and Low Range of Xenetic Biosciences Stock (XBIO)?

  • 52 Week High

    $5.20

  • 52 Week Low

    $2.78

What are the historical returns of Xenetic Biosciences (XBIO)?

  • 1 Month Returns

    -4.19%

  • 3 Months Returns

    2.37%

  • 1 Year Returns

    -8.07%

  • 5 Years Returns

    -49.99%

Who is the Chief Executive Officer (CEO) of Xenetic Biosciences ?

Mr. James F. Parslow is the current Chief Executive Officer (CEO) of Xenetic Biosciences.